Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 14 studies | 25% ± 7% | |
| naive B cell | 13 studies | 23% ± 6% | |
| endothelial cell | 12 studies | 30% ± 13% | |
| non-classical monocyte | 7 studies | 32% ± 14% | |
| memory B cell | 7 studies | 22% ± 4% | |
| endothelial cell of lymphatic vessel | 6 studies | 21% ± 5% | |
| classical monocyte | 6 studies | 28% ± 10% | |
| plasmacytoid dendritic cell | 6 studies | 24% ± 10% | |
| hematopoietic precursor cell | 5 studies | 34% ± 15% | |
| endothelial cell of artery | 5 studies | 24% ± 7% | |
| vein endothelial cell | 5 studies | 29% ± 9% | |
| conventional dendritic cell | 4 studies | 37% ± 14% | |
| immature B cell | 4 studies | 27% ± 5% | |
| pancreatic D cell | 3 studies | 50% ± 22% | |
| endothelial cell of vascular tree | 3 studies | 20% ± 2% | |
| precursor B cell | 3 studies | 24% ± 8% | |
| pro-B cell | 3 studies | 25% ± 6% | |
| dendritic cell | 3 studies | 33% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 3512.00 | 226 / 226 | 100% | 62.00 | 405 / 406 |
| thymus | 100% | 8388.04 | 652 / 653 | 95% | 172.60 | 572 / 605 |
| pancreas | 100% | 1409.50 | 327 / 328 | 89% | 23.55 | 159 / 178 |
| lung | 99% | 1060.56 | 573 / 578 | 81% | 12.27 | 940 / 1155 |
| breast | 100% | 876.30 | 458 / 459 | 79% | 13.11 | 879 / 1118 |
| adrenal gland | 100% | 1338.81 | 257 / 258 | 63% | 10.90 | 145 / 230 |
| uterus | 97% | 607.94 | 165 / 170 | 65% | 7.98 | 300 / 459 |
| esophagus | 83% | 412.21 | 1204 / 1445 | 72% | 12.51 | 131 / 183 |
| kidney | 88% | 391.72 | 78 / 89 | 59% | 7.83 | 534 / 901 |
| bladder | 100% | 766.57 | 21 / 21 | 46% | 5.44 | 230 / 504 |
| intestine | 98% | 725.30 | 949 / 966 | 44% | 6.16 | 230 / 527 |
| stomach | 78% | 288.86 | 280 / 359 | 60% | 10.63 | 171 / 286 |
| prostate | 89% | 361.15 | 217 / 245 | 34% | 2.67 | 172 / 502 |
| skin | 51% | 189.68 | 924 / 1809 | 71% | 12.97 | 335 / 472 |
| brain | 41% | 129.86 | 1084 / 2642 | 61% | 6.01 | 430 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 29.39 | 29 / 29 |
| spleen | 100% | 2931.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.92 | 1 / 1 |
| ovary | 44% | 159.07 | 79 / 180 | 56% | 5.65 | 240 / 430 |
| adipose | 99% | 1095.87 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 73% | 1375.05 | 680 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 6.86 | 32 / 45 |
| blood vessel | 70% | 326.28 | 933 / 1335 | 0% | 0 | 0 / 0 |
| heart | 60% | 184.62 | 514 / 861 | 0% | 0 | 0 / 0 |
| muscle | 17% | 49.54 | 139 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.40 | 5 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0010621 | Biological process | negative regulation of transcription by transcription factor localization |
| GO_0030948 | Biological process | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO_0010944 | Biological process | negative regulation of transcription by competitive promoter binding |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0016525 | Biological process | negative regulation of angiogenesis |
| GO_0006406 | Biological process | mRNA export from nucleus |
| GO_0071103 | Biological process | DNA conformation change |
| GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0030154 | Biological process | cell differentiation |
| GO_0034504 | Biological process | protein localization to nucleus |
| GO_0009952 | Biological process | anterior/posterior pattern specification |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0045736 | Biological process | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_0070663 | Biological process | regulation of leukocyte proliferation |
| GO_0016973 | Biological process | poly(A)+ mRNA export from nucleus |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0030183 | Biological process | B cell differentiation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0032993 | Cellular component | protein-DNA complex |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0017025 | Molecular function | TBP-class protein binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0140297 | Molecular function | DNA-binding transcription factor binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0008301 | Molecular function | DNA binding, bending |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| GO_0008190 | Molecular function | eukaryotic initiation factor 4E binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | HHEX |
| Protein name | Hematopoietically expressed homeobox Hematopoietically-expressed homeobox protein HHEX (Homeobox protein HEX) (Homeobox protein PRH) (Proline-rich homeodomain protein) |
| Synonyms | HEX PRHX PRH |
| Description | FUNCTION: Recognizes the DNA sequence 5'-ATTAA-3' (By similarity). Transcriptional repressor (By similarity). Activator of WNT-mediated transcription in conjunction with CTNNB1 . Establishes anterior identity at two levels; acts early to enhance canonical WNT-signaling by repressing expression of TLE4, and acts later to inhibit NODAL-signaling by directly targeting NODAL (By similarity). Inhibits EIF4E-mediated mRNA nuclear export . May play a role in hematopoietic differentiation . . |
| Accessions | ENST00000282728.10 Q03014 F8VU08 ENST00000472590.6 ENST00000492654.3 |